|

A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients

RECRUITINGN/ASponsored by The University of Hong Kong
Actively Recruiting
PhaseN/A
SponsorThe University of Hong Kong
Started2024-04-22
Est. completion2026-03-31
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted

Summary

Lung cancers patients often experience multiple symptoms (e.g. fatigue, dyspnea, distress, depression, sleep disturbance). The current study attempts to explore the efficacy of the Smart Self-Management Support Programme (3S) in improving quality of life of patients using self-management support programme with mobile devices.

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Patients:

Inclusion Criteria:

* Aged 18 years or above
* Diagnosis of advanced-stage (stage III or stage IV) non-small cell lung cancer
* Ambulatory and capable of all self-care activities (ECOG ≤2)
* Either undergoing or has finished oncology therapy
* Mentally, cognitively and physically fit to join as determined by the doctor in charge and responsible clinical investigators
* Can speak and read Chinese
* Willing to complete the patient-reported outcome questionnaire
* Has a smartphone with WhatsApp or WeChat

Exclusion Criteria:

* Preparing for lung operation
* Skeletal fragility
* Serious active infection
* Inability to walk
* Previously untreated symptomatic brain metastases
* Severe respiratory insufficiency
* Uncontrolled pain
* Diagnosed psychiatric illness with or without medication

Family Caregivers:

Inclusion criteria:

* Aged 18 years or above
* Family caregivers of recruited patients

Exclusion criteria:

* Unable to speak and read Chinese
* Unwilling to complete the patient-reported outcome questionnaire

Conditions2

CancerLung Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.